0001127602-25-019258.txt : 20250716 0001127602-25-019258.hdr.sgml : 20250716 20250716141956 ACCESSION NUMBER: 0001127602-25-019258 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250715 FILED AS OF DATE: 20250716 DATE AS OF CHANGE: 20250716 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reidy Christopher R CENTRAL INDEX KEY: 0001290907 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10315 FILM NUMBER: 251127021 MAIL ADDRESS: STREET 1: ONE ADP BLVD CITY: ROSELAND STATE: NJ ZIP: 07068 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Encompass Health Corp CENTRAL INDEX KEY: 0000785161 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 630860407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9001 LIBERTY PARKWAY CITY: BIRMINGHAM STATE: AL ZIP: 35242 BUSINESS PHONE: 205-967-7116 MAIL ADDRESS: STREET 1: 9001 LIBERTY PARKWAY CITY: BIRMINGHAM STATE: AL ZIP: 35242 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHSOUTH CORP DATE OF NAME CHANGE: 19950113 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHSOUTH REHABILITATION CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2025-07-15 0000785161 Encompass Health Corp EHC 0001290907 Reidy Christopher R 9001 LIBERTY PARKWAY BIRMINGHAM AL 35242 1 0 Encompass Health Common Stock 2025-07-15 4 A 0 17 0 A 14448 D Encompass Health Common Stock 2025-07-16 4 A 0 333 106.89 A 14781 D Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2025, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $107.28. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2024 to defer fixed percentages of their director fees for 2025. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the quarterly fee deferral and the dividend of $0.17 per share paid on July 15, 2025 This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $106.82 to $106.89, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. /s/ Patrick Darby, attorney-in-fact for Christopher R. Reidy 2025-07-16